Forbes article on product hopping

https://www.forbes.com/sites/theapothecary/2024/05/21/how-drug-companies-stifle-competition-with-product-hopping/

FTC comment to Patent Office

https://www.ftc.gov/system/files/ftc_gov/pdf/FTC-Comment-on-USPTO-Terminal-Disclaimer-NPRM-7-9-2024.pdf

Statement of Commissioner Slaughter

https://www.ftc.gov/system/files/ftc_gov/pdf/2410004exxonrksstmt_0.pdf